المؤلفون: N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika

المصدر: Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 5, Pp 138-145 (2020)

مصطلحات موضوعية: highly active multiple sclerosis, disease-modifying drugs for multiple sclerosis, cladribine tablets, Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

Relation: https://nnp.ima-press.net/nnp/article/view/1459; https://doaj.org/toc/2074-2711; https://doaj.org/toc/2310-1342

URL الوصول: https://doaj.org/article/5f178b23c350496eb61e04a1caa188bb